IP Library Granted Patent US 8,802,728
Granted Patent B2
US 8,802,728 · App. 13/883,803 · Granted Aug 12, 2014

Analgesic compounds, methods, and formulations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,802,728
App. No.
13/883,803
Granted
Aug 12, 2014
Kind
B2
Abstract

Provided are analgesic compounds, and salts thereof, of formula: (I) wherein A is: (A) Additionally, pharmaceutical formulations and methods of use employing the above compounds are provided.

Claims (145)

1. A compound, or salt thereof, of formula I:

wherein A is

R 1 is hydrogen, C 1 -C 5 alkyl, C 1 -C 5 haloalkyl, C 1 -C 5 alkanol, —(C 1 -C 5 alkyl)phenyl, or phenyl, or a group of the formula —C(O)—R 12 , where R 12 is C 1 -C 5 alkyl, C 1 -C 5 alkoxy, C 1 -C 5 haloalkyl, C 1 -C 5 alkanol, —(C 1 -C 5 alkyl)phenyl, or phenyl;

R 2 is hydrogen, C 1 -C 5 alkyl, C 1 -C 5 alkoxy, halogen, C 1 -C 5 haloalkyl, or C 1 -C 5 haloalkoxy;

R 3 is hydrogen, C 1 -C 5 alkyl, C 1 -C 5 alkoxy, halogen, C 1 -C 5 haloalkyl, or C 1 -C 5 haloalkoxy;

R 4 is hydrogen, C 1 -C 5 alkyl, or —(C 1 -C 5 alkyl)phenyl;

R 5 is hydrogen, C 1 -C 5 alkyl, or —(C 1 -C 5 alkyl)phenyl;

R 6 is hydrogen, hydroxy, or is absent;

R 7 is hydrogen;

R 8 is hydrogen or methyl;

R 9 is hydrogen or methyl;

R 10 is hydrogen;

R 11 is hydrogen or C 1 -C 5 alkyl;

provided that one of A), B), and C) is present, wherein A), B) and C) are:

A) R 7 and R 10 combine to form —CH 2 — or —(CH 2 ) 2 —;

B) R 8 and R 9 combine to form a cyclopropyl group with the carbon to which they are attached; and

C) R 10 and R 11 combine to form —CH 2 — or —(CH 2 ) 3 .

2. The compound of claim 1 wherein A is selected from

3. The compound of claim 2 of the formula Ia:

or a salt thereof.

4. The compound of claim 2 wherein it is

2-dimethylaminomethyl-3-(3-methoxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(3-fluoro-5-methoxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(5-methoxy-2-trifluoromethoxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(2-fluoro-5-methoxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(4-fluoro-3-methoxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(2-fluoro-3-methoxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(3-methoxy-5-methyl-phenyl)-bicyclo[3.2.1]octan-3-ol;

3-(2-chloro-5-methoxy-phenyl)-2-dimethylaminomethyl-bicyclo[3.2.1]octan-3-ol;

3-(3-chloro-5-methoxyphenyl)-2-dimethylaminomethyl-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(5-methoxy-2-methyl-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(3-methoxy-4-methyl-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(3-hydroxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(2-fluoro-5-hydroxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(3-fluoro-5-hydroxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(3-hydroxy-5-trifluoromethyl-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(5-hydroxy-2-trifluoromethoxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(3-hydroxy-4-trifluoromethyl-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(4-fluoro-3-hydroxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(2-fluoro-3-hydroxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(3-hydroxy-5-methyl-phenyl)-bicyclo[3.2.1]octan-3-ol;

3-(2-chloro-5-hydroxy-phenyl)-2-dimethylaminomethyl-bicyclo[3.2.1]octan-3-ol;

3-(3-chloro-5-hydroxy-phenyl)-2-dimethylaminomethyl-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(5-hydroxy-2-methyl-phenyl)-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(3-hydroxy-4-methyl-phenyl)-bicyclo[3.2.1]octan-3-ol;

3-(3,4-difluoro-5-hydroxy-phenyl)-2-dimethylaminomethyl-bicyclo[3.2.1]octan-3-ol;

2-dimethylaminomethyl-3-(2-fluoro-5-hydroxy-phenyl)-bicyclo[3.2.1]octan-3-ol;

2,2-dimethyl-propionic acid 3-(2-dimethylaminomethyl-3-hydroxy-bicyclo[3.2.1]oct-3-yl)-4-fluoro-phenyl ester;

benzoic acid 3-(2-dimethylaminomethyl-3-hydroxy-bicyclo[3.2.1]oct-3-yl)-4-fluoro-phenyl ester;

2,2-dimethyl-propionic acid 3-(2-dimethylaminomethyl-3-hydroxy-bicyclo[3.2.1]oct-3-yl)-phenyl ester;

benzoic acid 3-(2-dimethylaminomethyl-3-hydroxy-bicyclo[3.2.1]oct-3-yl)-phenyl ester;

2,2-dimethyl-propionic acid 3-(2-dimethylaminomethyl-3-hydroxy-bicyclo[3.2.1]oct-3-yl)-5-fluoro-phenyl ester; or

benzoic acid 3-(2-dimethylaminomethyl-3-hydroxy-bicyclo[3.2.1]oct-3-yl)-5-fluoro-phenyl ester;

or a salt thereof.

5. The compound of claim 2 of the formula Ib:

or a salt thereof.

6. The compound of claim 2 wherein it is

3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-phenol;

[3-(3-methoxy-phenyl)-bicyclo[3.2.1]oct-3-en-2-ylmethyl]-dimethyl-amine;

[3-(5-methoxy-2-trifluoromethoxy-phenyl)-bicyclo[3.2.1]oct-3-en-2-ylmethyl]-dimethyl-amine;

3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-4-trifluoromethoxy-phenol;

[3-(3-fluoro-5-methoxy-phenyl)-bicyclo[3.2.1]oct-3-en-2-ylmethyl]-dimethyl-amine;

3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-5-fluoro-phenol;

[3-(2-fluoro-5-methoxy-phenyl)-bicyclo[3.2.1]oct-3-en-2-ylmethyl]-dimethyl-amine;

3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-4-fluoro-phenol;

[3-(3-methoxy-5-methyl-phenyl)-bicyclo[3.2.1]oct-3-en-2-ylmethyl]-dimethyl-amine;

3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-5-methyl-phenol;

3-chloro-5-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-phenol;

[3-(5-methoxy-2-methyl-phenyl)-bicyclo[3.2.1]oct-3-en-2-ylmethyl]-dimethyl-amine;

3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-4-methyl-phenol;

4-chloro-3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-phenol;

2,2-dimethyl-propionic acid 3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-phenyl ester;

benzoic acid 3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-phenyl ester;

2,2-dimethyl-propionic acid 3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-5-fluorophenyl ester;

isobutyric acid 3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-5-fluoro-phenyl ester;

2,2-dimethyl-propionic acid 3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-4-fluoro-phenyl ester; or

isobutyric acid 3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-4-fluoro-phenyl ester;

or a salt thereof.

7. The compound of claim 2 wherein it is of the formula Ic:

or a salt thereof.

8. The compound of claim 2 wherein it is:

3-(2-dimethylaminomethyl-bicyclo[3.2.1]oct-3-yl)-phenol;

[3-(3-methoxy-phenyl)-bicyclo[3.2.1]oct-2-ylmethyl]-dimethyl-amine;

3-(2-dimethylaminomethyl-bicyclo[3.2.1]oct-3-yl)-5-fluoro-phenol;

[3-(3-fluoro-5-methoxy-phenyl)-bicyclo[3.2.1]oct-2-ylmethyl]-dimethyl-amine;

3-(2-dimethylaminomethyl-bicyclo[3.2.1]oct-3-yl)-4-fluoro-phenol;

[3-(2-fluoro-5-methoxy-phenyl)-bicyclo[3.2.1]oct-2-ylmethyl]-dimethyl-amine;

3-(2-dimethylaminomethyl-bicyclo[3.2.1]oct-3-yl)-5-methyl-phenol;

[3-(3-methoxy-5-methyl-phenyl)-bicyclo[3.2.1]oct-2-ylmethyl]-dimethyl-amine;

2,2-dimethyl-propionic acid 3-(2-dimethylaminomethyl-bicyclo[3.2.1]oct-3-yl)-phenyl ester;

benzoic acid 3-(2-dimethylaminomethyl-bicyclo[3.2.1]oct-3-yl)-phenyl ester;

2,2-dimethyl-propionic acid 3-(2-dimethylaminomethyl-bicyclo[3.2.1]oct-3-yl)-5-fluoro-phenyl ester;

isobutyric acid 3-(2-dimethylaminomethyl-bicyclo[3.2.1]oct-3-yl)-5-fluoro-phenyl ester;

2,2-dimethyl-propionic acid 3-(2-dimethylaminomethyl-bicyclo[3.2.1]oct-3-yl)-4-fluoro-phenyl ester;

or isobutyric acid 3-(2-dimethylaminomethyl-bicyclo[3.2.1]oct-3-yl)-4-fluoro-phenyl ester;

or a salt thereof.

9. The compound of claim 2 wherein it is of the formula Id:

or a salt thereof.

10. The compound of claim 2 wherein it is

3-dimethylaminomethyl-2-(3-hydroxy-phenyl)-bicyclo[4.1.0]heptan-2-ol;

3-dimethylaminomethyl-2-(3-methoxy-phenyl)-bicyclo[4.1.0]heptan-2-ol;

3-dimethylaminomethyl-2-(3-fluoro-5-methoxy-phenyl)-bicyclo[4.1.0]heptan-2-ol;

3-dimethylaminomethyl-2-(5-methoxy-2-methyl-phenyl)-bicyclo[4.1.0]heptan-2-ol;

3-dimethylaminomethyl-2-(3-methoxy-phenyl)-5,5-dimethyl-bicyclo[4.1.0]heptan-2-ol;

3-dimethylaminomethyl-2-(3-hydroxy-phenyl)-5,5-dimethyl-bicyclo[4.1.0]heptan-2-ol;

3-dimethylaminomethyl-2-(3-fluoro-5-hydroxy-phenyl)-bicyclo[4.1.0]heptan-2-ol;

3-dimethylaminomethyl-2-(2-fluoro-5-hydroxy-phenyl)-bicyclo[4.1.0]heptan-2-ol;

3-dimethylaminomethyl-2-(3-hydroxy-5-methyl-phenyl)-bicyclo[4.1.0]heptan-2-ol;

2,2-dimethyl-propionic acid 3-(3-dimethylaminomethyl-2-hydroxy-bicyclo[4.1.0]hept-2-yl)-5-fluoro-phenyl ester; or

2,2-dimethyl-propionic acid 3-(3-dimethylaminomethyl-2-hydroxy-bicyclo[4.1.0]hept-2-yl)-4-fluoro-phenyl ester;

or a salt thereof.

11. The compound of claim 2 wherein it is of the formula Ie:

or a salt thereof.

12. The compound of claim 11 wherein it is

(1R,2R,3S,4S,5S)-3-(3-hydroxyphenyl)-2,6,6-trimethyl-4-((methyl(phenethyl)amino)methyl)bicyclo[3.1.1]heptan-3-ol;

(1R,2R,3S,4S,5S)-3-(3-methoxyphenyl)-2,6,6-trimethyl-4-((methyl(phenethyl)amino)methyl)bicyclo[3.1.1]heptan-3-ol;

(1S,2S,3R,4R,5R)-3-(3-hydroxyphenyl)-2,6,6-trimethyl-4-((methyl(phenethyl)amino)methyl)bicyclo[3.1.1]heptan-3-ol;

(1S,2S,3R,4R,5R)-3-(3-methoxyphenyl)-2,6,6-trimethyl-4-((methyl(phenethyl)amino)methyl)bicyclo[3.1.1]heptan-3-ol;

or a salt thereof.

13. The compound of claim 2 wherein it is of the formula If:

or a salt thereof.

14. The compound of claim 13 wherein it is 5-((dimethylamino)methyl)-4-(3-hydroxyphenyl)octahydro-1H-inden-4-ol, or a salt thereof.

15. The compound of claim 2 wherein it is (+)-(1S,2R,3R,5R)-2-((dimethylamino)methyl)-3-(3-hydroxyphenyl)bicyclo[3.2.1]octan-3-ol;

(−)-(1R,2S,3S,5S)-2-((dimethylamino)methyl)-3-(3-hydroxyphenyl)bicyclo[3.2.1]octan-3-ol;

(S)-3-((1S,2R,3R,5R)-2-((dimethylamino)methyl)-3-hydroxybicyclo[3.2.1]octan-3-yl)phenyl 2-phenylpropanoate hydrochloride;

(S)-3-(1R,2S,3S,5S)-2-((dimethylamino)methyl)-3-hydroxybicyclo[3.2.1]octan-3-yl)phenyl 2-phenylpropanoate hydrochloride;

3-(4-dimethylaminomethyl-bicyclo[3.2.1]oct-2-en-3-yl)-phenol;

3-((1S,5R)-2-((dimethylamino)methyl)bicyclo[3.2.1]oct-2-en-3-yl)phenol; and salty or a salt thereof.

16. A compound of claim 2 wherein it is of the formula Ig:

or a salt thereof.

17. The compound of claim 16 where it is 5-dimethylaminomethyl-6-(2-fluoro-5-hydroxy-phenyl)-spiro[2.5]octan-6-ol, or a salt thereof.

18. The compound of claim 4 wherein it is 2-dimethylaminomethyl-3-(3-methoxy-5-methyl-phenyl)-bicyclo[3.2.1]octan-3-ol, or a salt thereof.

19. The compound of claim 4 wherein it is 2-dimethylaminomethyl-3-(3-hydroxy-5-methyl-phenyl)-bicyclo[3.2.1]octan-3-ol, or a salt thereof.

20. The compound of claim 10 wherein it is 3-dimethylaminomethyl-2-(3-fluoro-5-hydroxy-phenyl)-bicyclo[4.1.0]heptan-2-ol, or a salt thereof.

21. The compound of claim 10 wherein it is 3-dimethylaminomethyl-2-(2-fluoro-5-hydroxy-phenyl)-bicyclo[4.1.0]heptan-2-ol, or a salt thereof.

22. The compound of claim 10 wherein it is 2,2-dimethyl-propionic acid 3-(3-dimethylaminomethyl-2-hydroxy-bicyclo[4.1.0]hept-2-yl)-5-fluoro-phenyl ester, or a salt thereof.

23. The compound of claim 10 wherein it is 2,2-dimethyl-propionic acid 3-(3-dimethylaminomethyl-2-hydroxy-bicyclo[4.1.0]hept-2-yl)-4-fluoro-phenyl ester, or a salt thereof.

24. A pharmaceutical formulation comprising a compound claim 2 and one or more pharmaceutically acceptable carriers.

25. The pharmaceutical formulation of claim 24 wherein it further comprises at least one additional active ingredient.

26. The pharmaceutical formulation of claim 24 wherein it is a human pharmaceutical formulation.

27. The pharmaceutical formulation of claim 24 wherein it is a veterinary pharmaceutical formulation.

28. A method of controlling pain in a mammal in need thereof comprising administering an effective amount of a compound of claim 1 to said mammal.

29. The method of claim 28 wherein at least one other active ingredient is administered to said mammal.

30. The method of claim 28 wherein said mammal is a human.

31. The method of claim 28 wherein said mammal is a companion animal.

Assignments (5)
ASSIGNMENT OF SECURITY INTEREST IN PATENT RIGHTS, RECORDED ON AUGUST 3, 2020, AT REEL/FRAME 053388/0967 Recorded Dec 3, 2025
From: GOLDMAN SACHS BANK USA, AS RETIRING COLLATERAL AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 073816/0021 →
SECURITY INTEREST Recorded Aug 3, 2020
From: ELANCO US INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 053388/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: ELI LILLY AND COMPANY
To: ELANCO US INC.
Reel/Frame 044701/0261 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2013
From: CHEN, SHUHUI; ZHANG, YANG; WU, WENTAO; PENG, XIAN; MA, YUJUAN; LU, LUN
To: WUXI APPTEC CO., LTD.
Reel/Frame 030374/0405 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2013
From: DEFAUW, JEAN MARIE; HOLMSTROM, SCOTT DALE; WUXI APPTEC CO., LTD.
To: ELI LILLY AND COMPANY
Reel/Frame 030374/0508 →